Management for people with SLE and persistent aPL antibodies

For management of people with SLE who have persistent aPL antibodies but no clinical features to diagnose antiphospholipid syndrome, see Management for people with persistent aPL antibodies.

Other considerations for people with SLE and persistent aPL antibodies are the additive risks of thromboembolism if they:

• wish to use estrogen-containing contraceptives; contraindicated
• wish to conceive; see Considerations for people with SLE planning pregnancy
• are pregnant; see Management for people with SLE during pregnancy
• wish to use menopausal hormone therapy.